Dr. Naylor’s clinical and research expertise are in genetic and atypical forms of diabetes. She is a co-Investigator of the US National Monogenic Diabetes Registry housed at the University of Chicago, an investigator of the rare and atypical diabetes network, or RADIANT study and contributes to the American Diabetes Association Precision Medicine in Diabetes Initiative. Her work addresses barriers to accurate genetic diagnosis of MODY and inequities in who benefits from diabetes precision medicine. She has carried out cost-effectiveness analyses demonstrating the economic value of accurate genetic diagnosis of MODY and ongoing studies seek to clarify best management practices for MODY and support broader implementation of precision medicine in diabetes.
Approach to the Patient: Mitochondrial Diabetes: Contemporary Cases and a Precision Medicine Approach.
Approach to the Patient: Mitochondrial Diabetes: Contemporary Cases and a Precision Medicine Approach. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):1175-1186.
PMID: 41472381
Children With Pancreatic Hypoplasia Experience Poor Weight Gain and Labile Diabetes but Low Incidence of DKA.
Children With Pancreatic Hypoplasia Experience Poor Weight Gain and Labile Diabetes but Low Incidence of DKA. J Clin Endocrinol Metab. 2026 Mar 17; 111(4):e1164-e1173.
PMID: 41006196
Obstructive Sleep Apnea, Resting Heart Rate, and Glycemic Variability in Adults With Maturity-Onset Diabetes of the Young.
Obstructive Sleep Apnea, Resting Heart Rate, and Glycemic Variability in Adults With Maturity-Onset Diabetes of the Young. Diabetes. 2026 01 01; 75(1):215-222.
PMID: 41232044
Creation and Evaluation of a Research Participant Portal for the University of Chicago Monogenic Diabetes Registry.
Creation and Evaluation of a Research Participant Portal for the University of Chicago Monogenic Diabetes Registry. J Diabetes Sci Technol. 2025 Dec 11; 19322968251399666.
PMID: 41383073
Sleep patterns in adults and children with less common forms of diabetes.
Sleep patterns in adults and children with less common forms of diabetes. Front Endocrinol (Lausanne). 2025; 16:1388995.
PMID: 41158621
Antibody-Positive Type 1 Diabetes in a Family With a Pathogenic HNF1A-MODY Variant and Variable Age of Onset.
Antibody-Positive Type 1 Diabetes in a Family With a Pathogenic HNF1A-MODY Variant and Variable Age of Onset. JCEM Case Rep. 2025 Nov; 3(11):luaf229.
PMID: 41064662
GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series.
GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series. BMJ Open Diabetes Res Care. 2025 Apr 23; 13(2).
PMID: 40274278
Advancing Monogenic Diabetes Research and Clinical Care by Creating a Data Commons: The Precision Diabetes Consortium (PREDICT).
Advancing Monogenic Diabetes Research and Clinical Care by Creating a Data Commons: The Precision Diabetes Consortium (PREDICT). J Diabetes Sci Technol. 2026 May; 20(3):1034-1040.
PMID: 39781649
Precision treatment of beta-cell monogenic diabetes: a systematic review.
Precision treatment of beta-cell monogenic diabetes: a systematic review. Commun Med (Lond). 2024 Jul 18; 4(1):145.
PMID: 39025920
High Prevalence of A-ß+ Ketosis-Prone Diabetes in Children with Type 2 Diabetes and Diabetic Ketoacidosis at Diagnosis: Evidence from the Rare and Atypical Diabetes Network (RADIANT).
High Prevalence of A-ß+ Ketosis-Prone Diabetes in Children with Type 2 Diabetes and Diabetic Ketoacidosis at Diagnosis: Evidence from the Rare and Atypical Diabetes Network (RADIANT). Pediatr Diabetes. 2024; 2024.
PMID: 38765897